Mainstream

Aptargroup Projects Double Digit Eps Growth In 2025 Backed By Pharma And Closures Segments

AptarGroup projects double-digit EPS growth in 2025 backed by pharma and closures segments

AptarGroup projects double-digit EPS growth in 2025 backed by pharma and closures segments

Post ContentatrRead More

You might also be interested in reading Strategy Boosts Bitcoin Fundraise to $2B via Preferred Stock: Report.

February 8, 2025
In Mainstream